132 related articles for article (PubMed ID: 7046758)
1. Tiopronin (N-[2-mercaptopropionyl] glycin) in rheumatoid arthritis.
Amor B; Mery C; de Gery A
Arthritis Rheum; 1982 Jun; 25(6):698-703. PubMed ID: 7046758
[TBL] [Abstract][Full Text] [Related]
2. Controlled multicenter trial of tiopronin and d-penicillamine for rheumatoid arthritis.
Pasero G; Pellegrini P; Ambanelli U; Ciompi ML; Colamussi V; Ferraccioli G; Barbieri P; Mazzoni MR; Menegale G; Trippi D
Arthritis Rheum; 1982 Aug; 25(8):923-9. PubMed ID: 7115451
[TBL] [Abstract][Full Text] [Related]
3. Thiopronine therapy in rheumatoid arthritis.
Pasero G; Ciompi ML
Arthritis Rheum; 1979 Jul; 22(7):803-4. PubMed ID: 454510
[No Abstract] [Full Text] [Related]
4. Therapeutic effects of tiopronin on chronic hepatitis: a double-blind clinical study.
Ichida F; Shibasaki K; Takino T; Suzuki H; Fujisawa K; Inoue K; Hirayama C; Kaito I; Hirasawa T; Kameda H; Inoue J; Satoh G; Kosaka Y; Yamamoto S; Nagashima H; Tsuji T; Ohta Y; Okada J
J Int Med Res; 1982; 10(5):325-32. PubMed ID: 6128281
[TBL] [Abstract][Full Text] [Related]
5. Serum antioxidant activity and related variables in rheumatoid arthritis. Behaviour during sulphydrylant treatment.
Ambanelli U; Spisni A; Ferraccioli GF
Scand J Rheumatol; 1982; 11(4):203-7. PubMed ID: 7178856
[TBL] [Abstract][Full Text] [Related]
6. Tiopronin-nephropathy: clinical, pathological, immunological and immunogenetic characteristics.
Ferraccioli GF; Peri F; Nervetti A; Mercadanti M; Cavalieri F; Dall'Aglio PP; Savi M; Ferrari C
Clin Exp Rheumatol; 1986; 4(1):9-15. PubMed ID: 3516496
[TBL] [Abstract][Full Text] [Related]
7. Clinical efficacy and adverse effects of tiopronin in rheumatoid arthritis. Report of a follow-up in 50 patients.
Ambanelli U; Manganelli P; Ferraccioli GF
Z Rheumatol; 1982; 41(5):235-9. PubMed ID: 7158085
[TBL] [Abstract][Full Text] [Related]
8. Treatment of cystinuria with alpha-mercaptopropionylglycine.
Johansen K; Gammelgård PA; Jørgensen FS
Scand J Urol Nephrol; 1980; 14(2):189-92. PubMed ID: 7209424
[TBL] [Abstract][Full Text] [Related]
9. Thiopronine-induced pemphigus vulgaris in rheumatoid arthritis.
Trotta F; Scaramelli M; Cervi G; Virgili AR
Scand J Rheumatol; 1984; 13(1):93-5. PubMed ID: 6719065
[TBL] [Abstract][Full Text] [Related]
10. Effect of tiopronin on senile cataracts. A double-blind clinical study.
Ichikawa H; Imaizumi K; Tazawa Y; Obara Y; Ishikawa Y; Tobari I; Tanabe Y
Ophthalmologica; 1980; 180(5):293-8. PubMed ID: 7010262
[TBL] [Abstract][Full Text] [Related]
11. Management of cystine nephrolithiasis with alpha-mercaptopropionylglycine.
Pak CY; Fuller C; Sakhaee K; Zerwekh JE; Adams BV
J Urol; 1986 Nov; 136(5):1003-8. PubMed ID: 3534301
[TBL] [Abstract][Full Text] [Related]
12. A possible linkage of HLA-DRB haplotypes with Tiopronin intolerance in rheumatoid arthritis.
Ju LY; Paolozzi L; Delecoeuillerie G; Bourgeois P; Khodja M; Legoff P; Liote F; Sheffer V; Amor B; Charron D
Clin Exp Rheumatol; 1994; 12(3):249-54. PubMed ID: 7915222
[TBL] [Abstract][Full Text] [Related]
13. Mercaptopropionylglycine: a progress in cystine stone therapy.
Hautmann R; Terhorst B; Stuhlsatz HW; Lutzeyer W
J Urol; 1977 May; 117(5):628-30. PubMed ID: 870714
[TBL] [Abstract][Full Text] [Related]
14. [Tiopronin in 69 cases of rheumatoid polyarthritis treated earlier with D-penicillamine].
Sigaud M; Maugars Y; Maisonneuve H; Prost A
Rev Rhum Mal Osteoartic; 1988 Apr; 55(6):467-71. PubMed ID: 3134689
[TBL] [Abstract][Full Text] [Related]
15. Therapeutic effect of tiopronin following D-penicillamine toxicity in a patient with rheumatoid arthritis.
Matsukawa Y; Saito N; Nishinarita S; Horie T; Ryu J
Clin Rheumatol; 1998; 17(1):73-4. PubMed ID: 9586686
[No Abstract] [Full Text] [Related]
16. [Myasthenia caused by tiopronin during treatment of rheumatoid polyarthritis].
Menkes CJ; Job-Deslandre C; Bauer-Vinassac D; Rouillon A; Rousseau R
Presse Med; 1988 Jun; 17(22):1156-7. PubMed ID: 2969543
[No Abstract] [Full Text] [Related]
17. Long-term outcome with gold thiosulphate and tiopronin in 200 rheumatoid patients.
Ferraccioli GF; Salaffi F; Nervetti A; Manganelli P
Clin Exp Rheumatol; 1989; 7(6):577-81. PubMed ID: 2515016
[TBL] [Abstract][Full Text] [Related]
18. Serum IgA levels and ANA behaviour in rheumatoid patients with and without toxicity to remission-inducing drugs.
Ferraccioli GF; Nervetti A; Mercadanti M; Cavalieri F
Clin Exp Rheumatol; 1986; 4(3):217-20. PubMed ID: 2945684
[TBL] [Abstract][Full Text] [Related]
19. Antiarthritic drugs containing thiol groups scavenge hypochlorite and inhibit its formation by myeloperoxidase from human leukocytes. A therapeutic mechanism of these drugs in rheumatoid arthritis?
Cuperus RA; Muijsers AO; Wever R
Arthritis Rheum; 1985 Nov; 28(11):1228-33. PubMed ID: 2998407
[TBL] [Abstract][Full Text] [Related]
20. Comparison of 2-mercaptopropionylglycine and D-penicillamine in the treatment of cystinuria.
Harbar JA; Cusworth DC; Lawes LC; Wrong OM
J Urol; 1986 Jul; 136(1):146-9. PubMed ID: 3712602
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
